Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

Search Results

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

evt | Article | April 2018

Splenic Artery Embolization: Proximal or Distal?

A review of when proximal or distal embolization should be used, optimal technique, and results of studies evaluating outcomes.

By Hanno Hoppe, MD, EBIR, FCIRSE, and Sebastian Kos, MD, EBIR, FCIRSE

evt | Article | April 2018

Embolization: A Closer Look

By Christoph A. Binkert, MD, FCIRSE, FSIR, and Charles E. Ray Jr, MD, PhD, MS

evt | Article | November 2021

The Debate Continues: Current Perspectives on Routine Versus Selective Lumbar Drainage

Two viewpoints assessing the application of lumbar drainage.

With Martin Czerny, MD, MBA; Bartosz Rylski, MD; E. Hope Weissler, MD; and G. Chad Hughes, MD

evt | Article | November 2023

Where Do We Stand on Truly Uncomplicated TBAD? It’s Complicated

The management of uTBAD remains controversial—mostly due to difficulty identifying patients with truly uTBAD.

By Sophia Khan, MD, and Rana O. Afifi, MD

Advertisement

evt | Article | June 2024

An Interview With Nima Kokabi, MD, FRCPC

Dr. Kokabi explains his collaborative, personalized medicine approach to interventional oncology, knowledge gaps for Y90 dosimetry for hepatocellular carcinoma, updates on the Road2IR training program in East Africa, and more.

Sponsored by The PERT Consortium™

evt | Article | July 2024 Supplement

Redefining the Standard in PE Care

Ten years of The National PERT Consortium™.

By Rachel P. Rosovsky, MD, MPH; Michelle Lanno; and John Moriarty, MD

evt | News | March 23, 2021

Japan Approves PROMISE II Trial to Evaluate LimFlow’s pDVA System for CLTI

March 23, 2021—LimFlow SA announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has approved the company’s Clinical Trial Notification for the Japanese cohort of the ongoing pivotal PROMISE II trial of the LimFlow percutaneous deep vein arterialization (pDVA) system for the treatment of chronic limb-threatening ischemia (CLTI).

Sponsored by The PERT Consortium®

evt | Article | July 2020 Supplement

Introduction

By Brent Keeling, MD, and Richard Channick, MD

Sponsored by The PERT Consortium™

evt | Article | July 2023 Supplement

On the Horizon of PE Care

An update from The National PERT Consortium™.

Sponsored by The PERT Consortium™

evt | Article | July 2022 Supplement

Mission Possible!

Updates From The PERT Consortium™

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button